Mednow
strategic acquisition of canada and liver specialty group acquires canada acquires liver specialty group adds specialty pharmacy to offering biologic drugs make up of patented pharmaceutical sales in canada increases specialty pharmacy services and to include hepatology and the treatment of liver disease in of top selling patented pharmaceuticals were biologic drugs compared to in services over patient visits annually both virtually and in person expands logistical infrastructure in southwestern by increasing more densely populated cities in hepatitis medications accounted for the third class of drug by percentage of public drug spending in canada | Mednow
Company
Deck date
May 2022
Slide
38 of 39
Similar slides by Mednow
Investor Presentation
July 2022
Other recent decks by Mednow
Investor Presentation
August 2023
Investor Presentation
June 2023
Investor Presentation
January 2023
Investor Presentation
November 2022
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io